Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2017-01-19, 09:12:17 | version 1.38.0
INDUSTRY Implant Tribune U.S. Edition | September 2016 B6 AD At symposium, Nobel Biocare unveils new innovations to enhance restorative worklow By Nobel Biocare Staff N obel Biocare recently wel- comed dental professionals from around the world to the iconic Waldorf Astoria hotel in New York City for the Nobel Biocare Global Symposium 2016. The program for the sellout event in- cluded lectures, hands-on training and master classes from the world’s leading experts in implant dentistry. Under the banner “Where Innovation Comes to Life,” Nobel Biocare unveiled a number of innovative new products and solutions at the event. According to the company, each is designed to help dental profes- sionals treat more patients better, and many are so unique they are either pat- ent protected or in the patent process. Enhancing workflows for shorter time-to-teeth The Nobel Biocare Global Symposium showcased the role that digital technol- ogy plays in increasing the eficiency and accuracy of diagnostics, treatment plan- ning and guided surgery. Attendees were able to visit a digitally enabled practice exhibit featuring current technology as well as potential future innovations de- signed to increase integration, collabora- tion and eficiency. Participants could see how Nobel Biocare’s leading integrated worklow can accelerate, combine or even eliminate treatment steps, the company asserts. Nobel Biocare is also advancing the restorative worklow in terms of compo- nentry. An important new addition to Nobel Biocare’s assortment of compo- nents is the On1 concept.1 This modular solution bridges the gap between the sur- gical and prosthetic worklows. The On1 Base connects to the implant at surgery and then remains in place throughout the healing process, prosthetic work and then the lifetime of the restoration. This leaves the soft tissue undisturbed with- out compromising on restorative lexibil- ity, leaving the biological seal it creates in place for optimized healing, according to Nobel. As the On1 Base is seated at implant placement, the concept offers the sur- geon peace of mind that only precision- engineered Nobel Biocare components are used with the implant, removing risks associated with using third-party abutments. It also eliminates the risk that non-biocompatible, unclean or re- used components come into contact with the soft tissue. For a restorative clinician, the On1 Base allows for an improved patient experi- ence, as the discomfort previously asso- ciated with the removal of healing abut- ments can be completely avoided. With two height options available, there is the lexibility to change the On1 Base should the thickness of the soft tissue require it in the short or long term — an option not available with tissue-level implants, the company states. As the healing cap of the On1 concept supports an intraoral scan- ning approach, conventional impression- taking procedures for delivery of the i- nal crown can be eliminated. Nobel Biocare also presented the evo- lution of the NobelProcera at the sym- posium. This includes the launch of the new NobelProcera Crown, the irst in a series of options in a new high- translucency multilayered full-contour zirconia material. This new material pos- sesses exceptional properties, combin- ing high strength and durability with excellent esthetics, the company asserts. Nobel states it is now easier than ever to obtain precision-engineered Nobel- Procera restorations. One route is via the new NobelDesign CAD software, which offers dental technicians powerful CAD tools with an intuitive and adaptive in- terface. Another access point is Nobel- Procera Scan and Design Services. Advancing edentulous solutions As a leader in edentulous treatment and the company behind the revolutionary All-on-4® treatment concept, Nobel Bio- care is committed to further advancing the standard of care for edentulous pa- tients. NobelSpeedy, the original and widely documented implant for the All-on-4 treatment concept, is now available in more lengths and diameters for in- creased surgical lexibility. With new shorter 7 mm, longer 20, 22 and 25 mm implants and a wider 5 mm implant vari- ant, this expanded range is designed to further help clinicians utilize a graftless approach and achieve cortical anchorage where bone quality and quantity are lim- ited, allowing more patients to beneit from the proven advantages of the All- on-4 treatment concept. For more information about the Nobel Biocare Global Symposium 2016, visit nobelbiocare.com/global-symposium-2016.